Phase 1 Phase 2 Phase 3 Approval Launch IgG Next Generation (BT595) - Primary Immune Deficiency (PID) IgG Next Generation (BT595) - Idiopathic Thrombocytopenic Purpura (ITP) Fibrinogen (BT524) - Congenital fibrinogen deficiency Fibrinogen (BT524) - Acquired fibrinogen deficiency Trimodulin (BT588) - "Severe" COVID-19 Trimodulin (BT588) - Severe community acquired pneumonia Haemophilia A Therapeutic (HAT) - Haemophilia A Pipeline Pipeline
